Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6

Nature volume 525, pages 389–393 (2015)Cite this article

Subjects

Abstract

Epigenetic modifiers have fundamental roles in defining unique cellular identity through the establishment and maintenance of lineage-specific chromatin and methylation status1. Several DNA modifications such as 5-hydroxymethylcytosine (5hmC) are catalysed by the ten eleven translocation (Tet) methylcytosine dioxygenase family members2, and the roles of Tet proteins in regulating chromatin architecture and gene transcription independently of DNA methylation have been gradually uncovered3. However, the regulation of immunity and inflammation by Tet proteins independent of their role in modulating DNA methylation remains largely unknown. Here we show that Tet2 selectively mediates active repression of interleukin-6 (IL-6) transcription during inflammation resolution in innate myeloid cells, including dendritic cells and macrophages. Loss of Tet2 resulted in the upregulation of several inflammatory mediators, including IL-6, at late phase during the response to lipopolysaccharide challenge. Tet2-deficient mice were more susceptible to endotoxin shock and dextran-sulfate-sodium-induced colitis, displaying a more severe inflammatory phenotype and increased IL-6 production compared to wild-type mice. IκBζ, an IL-6-specific transcription factor, mediated specific targeting of Tet2 to the Il6 promoter, further indicating opposite regulatory roles of IκBζ at initial and resolution phases of inflammation. For the repression mechanism, independent of DNA methylation and hydroxymethylation, Tet2 recruited Hdac2 and repressed transcription of Il6 via histone deacetylation. We provide mechanistic evidence for the gene-specific transcription repression activity of Tet2 via histone deacetylation and for the prevention of constant transcription activation at the chromatin level for resolving inflammation.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Loss of Tet2 maintains higher expression of IL-6.
Figure 2: IκBζ mediates selective targeting of Tet2 to Il6 promoter.
Figure 3: Hdac2 associates with Tet2 and specifically represses IL-6 through histone deacetylation.
Figure 4: Tet2 recruits Hdac2 to repress expression of IL-6.

Accession codes

Primary accessions

Gene Expression Omnibus

Data deposits

The deep sequencing data have been deposited in the Gene Expression Omnibus under accession number GSE69256.

References

  1. Chen, T. & Dent, S. Y. Chromatin modifiers and remodellers: regulators of cellular differentiation. Nature Rev. Genet. 15, 93–106 (2014)

    Article  CAS  Google Scholar 

  2. Kohli, R. M. & Zhang, Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502, 472–479 (2013)

    Article  CAS  ADS  Google Scholar 

  3. Pastor, W. A., Aravind, L. & Rao, A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nature Rev. Mol. Cell Biol. 14, 341–356 (2013)

    Article  CAS  Google Scholar 

  4. Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930–935 (2009)

    Article  CAS  ADS  Google Scholar 

  5. Ko, M. et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468, 839–843 (2010)

    Article  CAS  ADS  Google Scholar 

  6. Szabo, S. J. et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295, 338–342 (2002)

    Article  CAS  ADS  Google Scholar 

  7. Tlaskalová-Hogenová, H. et al. Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Ann. NY Acad. Sci. 1051, 787–798 (2005)

    Article  ADS  Google Scholar 

  8. Neurath, M. F. Cytokines in inflammatory bowel disease. Nature Rev. Immunol. 14, 329–342 (2014)

    Article  CAS  Google Scholar 

  9. Ichiyama, K. et al. The methylcytosine dioxygenase tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells. Immunity 42, 613–626 (2015)

    Article  CAS  Google Scholar 

  10. Yamamoto, M. et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ. Nature 430, 218–222 (2004)

    Article  CAS  ADS  Google Scholar 

  11. Kayama, H. et al. Class-specific regulation of pro-inflammatory genes by MyD88 pathways and IκBζ. J. Biol. Chem. 283, 12468–12477 (2008)

    Article  CAS  Google Scholar 

  12. Hildebrand, D. G. et al. IκBζ is a transcriptional key regulator of CCL2/MCP-1. J. Immunol. 190, 4812–4820 (2013)

    Article  CAS  Google Scholar 

  13. Williams, K. et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473, 343–348 (2011)

    Article  CAS  ADS  Google Scholar 

  14. Chen, Q., Chen, Y., Bian, C., Fujiki, R. & Yu, X. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 493, 561–564 (2013)

    Article  CAS  ADS  Google Scholar 

  15. Deplus, R. et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J. 32, 645–655 (2013)

    Article  CAS  Google Scholar 

  16. Foster, S. L., Hargreaves, D. C. & Medzhitov, R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972–978 (2007)

    Article  CAS  ADS  Google Scholar 

  17. Qiao, Y. et al. Synergistic activation of inflammatory cytokine genes by interferon-gamma-induced chromatin remodeling and toll-like receptor signaling. Immunity 39, 454–469 (2013)

    Article  CAS  Google Scholar 

  18. Nicodeme, E. et al. Suppression of inflammation by a synthetic histone mimic. Nature 468, 1119–1123 (2010)

    Article  CAS  ADS  Google Scholar 

  19. Inoue, S., Mai, A., Dyer, M. J. & Cohen, G. M. Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 66, 6785–6792 (2006)

    Article  CAS  Google Scholar 

  20. Chen, X. et al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc. Natl Acad. Sci. USA 109, E2865–E2874 (2012)

    Article  CAS  Google Scholar 

  21. Moran-Crusio, K. et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 20, 11–24 (2011)

    Article  CAS  Google Scholar 

  22. Rampal, R. et al. DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. Cell Rep 9, 1841–1855 (2014)

    Article  CAS  Google Scholar 

  23. Liu, J. et al. Rhbdd3 controls autoimmunity by suppressing the production of IL-6 by dendritic cells via K27-linked ubiquitination of the regulator NEMO. Nature Immunol. 15, 612–622 (2014)

    Article  CAS  Google Scholar 

  24. Hunter, C. A. & Jones, S. A. IL-6 as a keystone cytokine in health and disease. Nature Immunol. 16, 448–457 (2015)

    Article  CAS  Google Scholar 

  25. Ma, F. et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nature Immunol. 12, 861–869 (2011)

    Article  CAS  Google Scholar 

  26. Liu, Y. et al. Histone lysine methyltransferase Ezh1 promotes TLR-triggered inflammatory cytokine production by suppressing Tollip. J. Immunol. 194, 2838–2846 (2015)

    Article  CAS  Google Scholar 

  27. Chen, W. et al. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell 152, 467–478 (2013)

    Article  CAS  Google Scholar 

  28. Xia, M. et al. Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20. Immunity 39, 470–481 (2013)

    Article  CAS  Google Scholar 

  29. Ito, S. et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466, 1129–1133 (2010)

    Article  CAS  ADS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Key Basic Research Program of China (2013CB530503) and the National Natural Science Foundation of China (31200654, 31390431, 81230074, 81123006).

Author information

Author notes

  1. Qian Zhang, Kai Zhao, Qicong Shen and Yanmei Han: These authors contributed equally to this work.

Authors and Affiliations

  1. National Key Laboratory of Medical Molecular Biology & Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100005, China

    Qian Zhang, Kai Zhao, Xia Li, Dezhi Zhao, Chunmei Wang, Wei Ge & Xuetao Cao

  2. National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai, 200433, China

    Qian Zhang, Qicong Shen, Yanmei Han, Yan Gu, Yiqi Liu, Xiang Zhang, Xiaoping Su, Juan Liu, Nan Li & Xuetao Cao

  3. Department of Medicine, Human Oncology and Pathogenesis Program and Leukemia Service, Memorial Sloan-Kettering Cancer, New York, 10016, New York, USA

    Ross L. Levine

Authors
  1. Qian Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kai Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qicong Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yanmei Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yan Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xia Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dezhi Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yiqi Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Chunmei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xiang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Xiaoping Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Juan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Wei Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Ross L. Levine
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Nan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Xuetao Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Q.Z., K.Z., Q.S. and Y.H. performed the experiments, analysed the data and contributed equally for the whole study. Y.G., X.L., D.Z., Y.L., C.W., X.Z., X.S., J.L., W.G. and N.L. provided reagents and performed experiments; RL.L. provided Tet2 KO mice. X.C. and Q.Z. analysed the data and wrote the manuscript. X.C. designed and supervised the study.

Corresponding author

Correspondence to Xuetao Cao.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Extended data figures and tables

Extended Data Figure 1 Loss of Tet2 specifically enhances expression of IL-6 but not TNF-α.

a, Hierarchical cluster of transcription level of chromatin modifiers with significant variation in LPS-stimulated murine BMDC, RPKMs were centred by the mean. b,Tet2 mRNA in human dendritic cells (hDC), LPS-stimulated murine BMDC, BMM and primary peritoneal macrophages (pMϕ). c–f, j, Human imDCs in which TET2 were lentivirally silenced (LV-siTET2), BMDC, BMM and peritoneal macrophages from Tet2-deficient mice (c–f), peritoneal macrophages from conditional Tet2-deficient mice (f, j) and their respective controls were stimulated by LPS for 8 h (c) or the indicated time (d, e, j). Protein levels of TET2 were detected by immunoblot, with lamin A/C as the loading control (c). IL-6 protein levels were analysed by ELISA (d), and Tnfa and Il6 mRNA levels were analysed by qPCR (e, j). Percentage of Iab+CD11c+BMDC or F4/80+ CD11b+peritoneal macrophages were analysed (f). g–i, Tet2 (g, h), Tet3 (g, i) were silenced in peritoneal macrophages for 48 h and then peritoneal macrophages were stimulated with LPS for 8 h (g, i) or the indicated time (h), and the protein levels of Tet2 or Tet3 were detected by immunoblot, with lamin A/C as the loading control (g).Tnfa and Il6 mRNA were analysed by qPCR (h, i). Full scans of blots are shown in Supplementary Fig. 1. Error bars represent s.e.m. of triplicate biological replicates and are representative of three independent experiments. **P < 0.01.

Extended Data Figure 2 Loss of Tet2 barely affects development of immune cells.

Percentages of the indicated immune cells were analysed by their specific lineage markers from control and Tet2-deficient mice. Data were from one representative of three independent experiments.

Extended Data Figure 3 Gene expression variation in Tet2-deficient dendritic cells.

a, b, mRNA variations of indicated genes in RNA-seq analysis of BMDC stimulated with LPS. RPKM of each of the genes in 4 h group were compared with 0 h group, and calculated to log2 ratio. c, d, qPCR analysis of mRNA levels of indicated genes in wild type and Tet2-deficient naive BMDC (c) or LPS-stimulated BMDC (d). e, BMDC were stimulated with LPS for 8 h, and then endogenous Tet2 enrichments at proximal promoter of indicated genes were analysed by ChIP-qPCR. Error bars represent s.d. of triplicate technical (e) or s.e.m. of triplicate biological (c, d) replicates and are representative of three independent experiments. **P < 0.01.

Extended Data Figure 4 Potential targets of Tet2 during immune response.

a–d, ELISA of cytokines in supernatants of splenic activated CD4+ T cells (a), CD8+ T cells (b) and NK cells (c), and conventional splenic CD19+ B cells (d) from Tet2-deficient (KO) and control mice (WT). T cells were stimulated with 10 μg ml−1 anti-CD3 and 1 μg ml−1 anti-CD28 monoclonal antibodies for 24 h. NK cells were stimulated with a combination of 10 ng ml−1 IL-12 plus 5 ng ml−1 IL-18 for 12 h. B cells were stimulated with 5 μg ml−1 LPS for 24 h, Error bars represent s.d. of triplicate technical replicates and are representative of three independent experiments. **P < 0.01.

Extended Data Figure 5 Loss of Tet2 barely affects TLR4 signalling pathways.

a, b, Immunoblot assays of the phosphorylated (p-) or total proteins in lysates of wild-type and Tet2-deficent BMDC (a) and peritoneal macrophages (b) stimulated with LPS for indicated time. Full scans of blots are shown in Supplementary Fig. 1. Data were from one representative of three independent experiments.

Extended Data Figure 6 Tet2 binding partners for cytokine regulation.

a, Co-immunoprecipitation assay using Tet2 antibody of nuclear fraction of murine BMDC stimulated with LPS for 8 h. Gene symbols of transcription factor deposited in KEGG database and their unique peptides identified by mass spectrometry analysis were tabled. b, IκBζ was silenced in BMDC using specific siRNA for 36 h and the BMDC were stimulated with LPS for 8 h. The protein levels of IκBζ were detected by immunoblot, with lamin A/C as the loading control. c, Hdac1/2 (blue circles) were subjected to interaction analysis with genes which had significant expression variations (red circles for upregulated, and green circles for downregulated) in BMDC 4 h after LPS stimulation. The linkers indicate interaction or regulation relationship between the two genes. d, e, Flag-tagged Hdac1 (d) or Hdac2 (e) were overexpressed in HEK293T cells together with Myc-tagged Tet2. Cell lysates were examined by IP and immunoblot with indicated antibodies. The whole-cell lysates (WCL) were used to examine the input of overexpressed proteins. f, BMDC were pretreated with 100 nM TSA for 1 h, and then stimulated by LPS for indicated time. mRNA levels of indicated genes were analysed by qPCR. g, h, BMDC (g) and peritoneal macrophages (h) were stimulated with LPS for the indicated time. Enrichments of H3Ac (g), H4Ac (h) at Tnf promoters were analysed by ChIP-qPCR. i, Hdac2 was silenced in BMDC for 48 h and then the BMDC were stimulated with LPS for 8 h. The protein levels of Hdac2 were detected by immunoblot, with lamin A/C as the loading control. Full scans of blots are shown in Supplementary Fig. 1. Error bars represent s.d. of triplicate technical (g, h) or s.e.m. of triplicate biological (f) replicates and are representative of three independent experiments. **P < 0.01.

Extended Data Figure 7 Tet2 represses Il6 promoter activity through recruiting Hdac2.

a, Luciferase activities in lysates of HEK293T cells transfected with indicated plasmids and luciferase reporter for murine Il6 promoter (TSS to upstream 3K). b, ChIP-qPCR analysis of Myc-tagged Tet3 in murine Il6 promoter in HEK293T cells which were transfected with indicated plasmids and luciferase reporter. c, ChIP-qPCR of Myc-tagged Tet2 or endogenous Hdac2 in murine Il6 promoter in HEK293T cells transfected with indicated plasmids and luciferase reporter. d, Hdac2 was silenced for 36 h in HEK293T cells. Protein levels of Hdac2 were detected by immunoblot, with lamin A/C as the loading control. e, Luciferase activities in lysates of Hdac2-silenced HEK293T cells transfected with indicated plasmids and luciferase reporter containing murine Il6 promoter. f, Wild-type (WT) and Tet2-deficient (KO) peritoneal macrophages were stimulated with LPS for 8 h. IP using O-GlcNAcylation antibody was performed. The whole-cell lysates (WCL) were used as the input. Full scans of blots are shown in Supplementary Fig. 1. Error bars represent s.d. of triplicate technical replicates and are representative of three independent experiments. **P < 0.01.

Supplementary information

Supplementary Information

This file contains Supplementary Figure 1, which shows the full scans of the blots and gels. (PDF 1032 kb)

Supplementary Data

This file contains Supplementary Table 1. (XLSX 18 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, Q., Zhao, K., Shen, Q. et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525, 389–393 (2015). https://doi.org/10.1038/nature15252

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature15252

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing